What is Metagenomi Therapeutics, Inc. Common Stock's Market Cap?

Metagenomi Therapeutics, Inc. Common Stock's Market Cap is $43.4M, based on as-reported figures from SEC (XBRL) filings.

What is Metagenomi Therapeutics, Inc. Common Stock's Enterprise Value?

Metagenomi Therapeutics, Inc. Common Stock's Enterprise Value is $4.4M, based on as-reported figures from SEC (XBRL) filings.

What is Metagenomi Therapeutics, Inc. Common Stock's Price / Sales?

Metagenomi Therapeutics, Inc. Common Stock's Price / Sales is 1.7×, based on as-reported figures from SEC (XBRL) filings.

What is Metagenomi Therapeutics, Inc. Common Stock's EV / Revenue?

Metagenomi Therapeutics, Inc. Common Stock's EV / Revenue is 0.2×, based on as-reported figures from SEC (XBRL) filings.

What is Metagenomi Therapeutics, Inc. Common Stock's EV / EBITDA?

Metagenomi Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Metagenomi Therapeutics, Inc. Common Stock's Revenue (TTM)?

Metagenomi Therapeutics, Inc. Common Stock's Revenue (TTM) is $25.2M, based on as-reported figures from SEC (XBRL) filings.

What is Metagenomi Therapeutics, Inc. Common Stock's Net Income (TTM)?

Metagenomi Therapeutics, Inc. Common Stock's Net Income (TTM) is -$93.5M, based on as-reported figures from SEC (XBRL) filings.

What is Metagenomi Therapeutics, Inc. Common Stock's EBITDA?

Metagenomi Therapeutics, Inc. Common Stock's EBITDA is -$95.4M, based on as-reported figures from SEC (XBRL) filings.

What is Metagenomi Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Metagenomi Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.47, based on as-reported figures from SEC (XBRL) filings.

What is Metagenomi Therapeutics, Inc. Common Stock's EBITDA Margin?

Metagenomi Therapeutics, Inc. Common Stock's EBITDA Margin is -378.4%, based on as-reported figures from SEC (XBRL) filings.

Metagenomi Therapeutics, Inc. Common Stock (MGX) Financial Statements

Metagenomi Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00Y5ZXS95

XNAS · usd

1.15▼ 0.01 (-0.86%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close1.16

Day's Range1.15 – 1.20

52-Week Range1.13 – 3.95

Volume147.5K

Avg Volume141.2K

Share Statistics

Shares Outstanding

Employees119

ExchangeXNAS

Listed2024-02-09

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Metagenomi Therapeutics, Inc. Common Stock (MGX)

What is Metagenomi Therapeutics, Inc. Common Stock's Market Cap?: Metagenomi Therapeutics, Inc. Common Stock's Market Cap is $43.4M, based on as-reported figures from SEC (XBRL) filings.
What is Metagenomi Therapeutics, Inc. Common Stock's Enterprise Value?: Metagenomi Therapeutics, Inc. Common Stock's Enterprise Value is $4.4M, based on as-reported figures from SEC (XBRL) filings.
What is Metagenomi Therapeutics, Inc. Common Stock's Price / Sales?: Metagenomi Therapeutics, Inc. Common Stock's Price / Sales is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is Metagenomi Therapeutics, Inc. Common Stock's EV / Revenue?: Metagenomi Therapeutics, Inc. Common Stock's EV / Revenue is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Metagenomi Therapeutics, Inc. Common Stock's EV / EBITDA?: Metagenomi Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Metagenomi Therapeutics, Inc. Common Stock's Revenue (TTM)?: Metagenomi Therapeutics, Inc. Common Stock's Revenue (TTM) is $25.2M, based on as-reported figures from SEC (XBRL) filings.
What is Metagenomi Therapeutics, Inc. Common Stock's Net Income (TTM)?: Metagenomi Therapeutics, Inc. Common Stock's Net Income (TTM) is -$93.5M, based on as-reported figures from SEC (XBRL) filings.
What is Metagenomi Therapeutics, Inc. Common Stock's EBITDA?: Metagenomi Therapeutics, Inc. Common Stock's EBITDA is -$95.4M, based on as-reported figures from SEC (XBRL) filings.
What is Metagenomi Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Metagenomi Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.47, based on as-reported figures from SEC (XBRL) filings.
What is Metagenomi Therapeutics, Inc. Common Stock's EBITDA Margin?: Metagenomi Therapeutics, Inc. Common Stock's EBITDA Margin is -378.4%, based on as-reported figures from SEC (XBRL) filings.